Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Endothelin-1 (ET-1) mediates pain states ranging from trauma to cancer. On page 1055 of this issue, Khodorova et al. map a new peripheral analgesic pathway involving ET-1. In this pathway, ET-1 is released locally by keratinocytes after cutaneous injury, and triggers pain through endothelin-A receptors of local nociceptors. ET-1 also coincidentally produces analgesia by activating endothelin-B receptors (ET-B) on keratinocytes, inducing them to secrete β-endorphin, which in turn binds to the local nociceptors. The cover depicts a confocal image of rat epidermis, localizing ET-B (orange) on the surface and β-endorphin (green) in the cytoplasm of keratinocytes in the upper epidermal layers. (Magnification, x20.)
Many Indian scientists have been tempted by the allure of the West—but not G. Padmanaban. At the tail end of a career that spans four decades, the biochemist has recently staked a more public presence, updating outdated notions of India and urging scientists to pursue a social mission.
Two new therapeutic strategies show promise in mouse models of hemophilia. One uses an RNA repair approach relying on trans-splicing to patch a genetic defect in a mouse model. Another aims at microparticles, cell fragments that seem to promote coagulation (pages 1015–1019 and 1020–1025).
Epilepsy remains a hard-to-treat disorder for millions of patients. Gene therapy to target brain regions with seizure-reducing compounds is one approach that has met with limited experimental success. An innovative form of genetic manipulation now reduces seizure susceptibility and seizure-induced brain injury in rats (pages 1076–1080).
Anthrax toxin is known to impair key signaling pathways, but exactly how does this damage the body or benefit the bacterium? Impairment of host immunity is now linked to an enzymatic activity of the toxin.
An approach that aims to correct RNA improves muscle function in a mouse model of a disease particularly recalcitrant to gene therapy: Duchenne muscular dystrophy (pages 1009–1014).
When do cancer cells acquire metastatic identity? Recent reports have indicated that the propensity to metastasize might be hardwired early during tumor development. Now it seems that breast cancer cells might acquire a gene signature early in tumorigenesis that predicts the site of metastasis.
Cadmium is a toxic environmental pollutant that has worrisome estrogenic effects in cell culture. New data from rats show that cadmium can act as an estrogen mimic in the whole animal, inducing conditions ranging from uterine hyperplasia to early onset of puberty (pages 1081–1084).